InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (6 ops.)
Insider track record
CEODisclosed buys
2
Disclosed sells
6
T+90 hit rate
27%
T+90 mean return
-9.6%
Across 11 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Chard Daniel R, Chairman & CEO. Director active across 1 company, notably MEDIFAST INC. In total, 21 disclosures have been published. Breakdown: 2 buys · 6 sells. Total volume traded: €1.5m. Activity tracked since 11 June 2021. The latest transaction was filed on 25 March 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations21 total
124,953 shares0Common StockSEC:0001628280-25-015270:0
5,001 shares@ US$13.873.2% of flowCommon StockSEC:0001628280-25-013669:0
608 shares@ US$36.611.0% of flowCommon StockSEC:0001628280-24-011973:0
45,087 shares0Common StockSEC:0001628280-24-011542:0
16,486 shares0Common StockSEC:0001628280-24-005407:0
34,076 shares0Common StockSEC:0001628280-23-014348:0
1,815 shares@ US$115.319.7% of flowCommon StockSEC:0001628280-23-004667:0
431.078 shares@ US$183.250.054% mcap4.3% of flowCommon StockSEC:0001104659-22-058937:0
Ideal exit: 30 Jan 2023 (T+270)
690.274 shares@ US$186.400.081% mcap6.5% of flowCommon StockSEC:0001104659-22-048540:0
Ideal exit: 1 Nov 2022 (T+270)
8,509 shares0Common StockSEC:0001104659-22-036227:0
1,804 shares@ US$177.060.20% mcap16.2% of flowCommon StockSEC:0001104659-22-026864:0
24,072 sharesCommon StockSEC:0001104659-22-000895
24,072 sharesCommon StockSEC:0001104659-22-000895:0
90,610 shares0Common StockSEC:0001104659-21-143174
90,610 shares0Common StockSEC:0001104659-21-143174:0
600 shares@ US$259.32256.5% of flowCommon StockSEC:0001562180-21-004412
600 shares@ US$259.32250.094% mcap7.5% of flowCommon StockSEC:0001562180-21-004412:0
300 shares@ US$274.51133.4% of flowCommon StockSEC:0001104659-21-082800
300 shares@ US$274.51130.049% mcap3.9% of flowCommon StockSEC:0001104659-21-082800:0
1,847 shares@ US$287.407121.6% of flowCommon StockSEC:0001104659-21-081619
1,847 shares@ US$287.40710.31% mcap25.1% of flowCommon StockSEC:0001104659-21-081619:0
21 of 21 declarations
About Chard Daniel R
Daniel R. Chard is Chairman and CEO of Medifast Inc. He is responsible for the strategic direction and management of the company's operations. With significant experience in the health and wellness industry, Daniel plays a key role in the growth and innovation of Medifast. His leadership is essential to achieving the company's objectives.
